Literature DB >> 12781095

[A comparative psychometric study of the Spanish versions with 6, 17, and 21 items of the Hamilton Depression Rating Scale].

Julio Bobes1, Antonio Bulbena, Antonio Luque, Rafael Dal-Ré, Javier Ballesteros, Nora Ibarra.   

Abstract

BACKGROUND AND
OBJECTIVE: Former Spanish studies on the Hamilton Depression Rating Scale (HDRS) have focused on the 17 items version and have been conducted in depressive in-patient series. This study compares the psychometric properties of the Spanish version of HDRS with 6, 17 and 21 items as assessed in depressive patients in ambulatory care. PATIENTS AND
METHOD: A prospective, observational and multicenter study was conducted in clinically stable or unstable depressed patients. The discriminative validity, reliability (internal consistency, test-retest and inter-raters) and sensitivity to change were assessed.
RESULTS: One hundred and sixty eight patients from 15 psychiatric facilities were included. The 6, 17 and 21 items versions of HDRS showed appropriate discriminative validity (HDRS-Clinical Global Impression: p < 0.0001); internal consistency (Cronbach *: HDRS-6 = 0.6; HDRS-17 and 21 >= 0.7); test-retest reliability (intraclass correlation coefficient [ICC]: HDRS-6, 17 and 21 >= 0.9); inter-raters reliability (ICC: HDRS-6, 17 and 21 >= 0.9) and sensitivity to change (effect size >= 1.5 for HDRS-6, 17 and 21).
CONCLUSIONS: Spanish versions of HDRS with 6, 17 and 21 items show similar psychometric properties. HDRS-6 could be useful in ambulatory and primary care.

Entities:  

Mesh:

Year:  2003        PMID: 12781095     DOI: 10.1016/s0025-7753(03)73814-7

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  20 in total

1.  Gene Expression, and Fatigue in Puerto Rican Men during Radiotherapy for Prostate Cancer: an Exploratory Study.

Authors:  Velda J Gonzalez; Leorey N Saligan; Brooke L Fridley; Humberto Ortiz-Zuazaga; Lauren S Aaronson
Journal:  P R Health Sci J       Date:  2017-12       Impact factor: 0.705

2.  Dose-response relationship of duloxetine in placebo-controlled clinical trials in patients with major depressive disorder.

Authors:  Per Bech; Daniel K Kajdasz; Vibeke Porsdal
Journal:  Psychopharmacology (Berl)       Date:  2006-09-08       Impact factor: 4.530

3.  A client-level session-by-session evaluation of behavioral activation's mechanism of action.

Authors:  Maria M Santos; James R Rae; Gabriela A Nagy; Katherine E Manbeck; Gabriela Diéguez Hurtado; Paul West; Azara Santiago-Rivera; Jonathan W Kanter
Journal:  J Behav Ther Exp Psychiatry       Date:  2016-07-07

4.  A Biomarker to Differentiate between Primary and Cocaine-Induced Major Depression in Cocaine Use Disorder: The Role of Platelet IRAS/Nischarin (I1-Imidazoline Receptor).

Authors:  Benjamin Keller; Joan-Ignasi Mestre-Pinto; María Álvaro-Bartolomé; Diana Martinez-Sanvisens; Magí Farre; M Julia García-Fuster; Jesús A García-Sevilla; Marta Torrens
Journal:  Front Psychiatry       Date:  2017-12-01       Impact factor: 4.157

5.  Burden, anxiety and depression in caregivers of Alzheimer patients in the Dominican Republic.

Authors:  Martin Medrano; Rebeca López Rosario; Anyolina Núñez Payano; Natacha Reynoso Capellán
Journal:  Dement Neuropsychol       Date:  2014 Oct-Dec

6.  Case Report: Clinical and Pharmacokinetic Profile of Lithium Monotherapy in Exclusive Breastfeeding. A Follow-Up Case Series.

Authors:  Maria Luisa Imaz; Dolors Soy; Mercé Torra; Llüisa García-Esteve; Cristina Soler; Rocio Martin-Santos
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

7.  Factors Affecting the Severity of Fatigue during Radiotherapy for Prostate Cancer; an Exploratory Study.

Authors:  Velda J Gonzalez-Mercado; Sara Marrero; Miguel A Marrero-Falcon; Leorey N Saligan
Journal:  Urol Nurs       Date:  2020 May-Jun

8.  Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder.

Authors:  Adriane R Rosa; Jose Sánchez-Moreno; Anabel Martínez-Aran; Manel Salamero; Carla Torrent; Maria Reinares; Mercè Comes; Francesc Colom; Willemijn Van Riel; Jose Luis Ayuso-Mateos; Flávio Kapczinski; Eduard Vieta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-06-07

9.  Individualized homeopathic treatment and fluoxetine for moderate to severe depression in peri- and postmenopausal women (HOMDEP-MENOP study): a randomized, double-dummy, double-blind, placebo-controlled trial.

Authors:  Emma Del Carmen Macías-Cortés; Lidia Llanes-González; Leopoldo Aguilar-Faisal; Juan Asbun-Bojalil
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

10.  Effectiveness of a multi-component Smoking Cessation Support Programme (McSCSP) for patients with severe mental disorders: study design.

Authors:  Maria Paz Garcia-Portilla; Leticia Garcia-Alvarez; Pilar Alejandra Saiz; Eva Diaz-Mesa; Gonzalo Galvan; Fernando Sarramea; Josefa Garcia-Blanco; Edorta Elizagarate; Julio Bobes
Journal:  Int J Environ Res Public Health       Date:  2013-12-24       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.